Kedudukan dalam Saham
#42632
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating... Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-08-11
Perubahan (1 tahun)
0.00%
Perdagangan Adynxx, Inc. (ADYX)
Harga ADYX dengan permodalan pasaran b
Modal pasaran bagi Adynxx, Inc.(ADYX)
Modal Pasaran: $581.00
Sehingga August 2026, Adynxx, Inc. mempunyai modal pasaran sebanyak $581.00. Ini menjadikan Adynxx, Inc. syarikat ke-42632nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Adynxx, Inc. dari 1998 hingga 2026
ADYX berbanding dengan 5 teratas yang paling popular stocks
| Harga ADYX |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.426T
|
+933,905,081,394.49%
|
|
|
|
|
$4.437T
|
+763,666,673,572.98%
|
|
|
|
|
$4.148T
|
+713,856,341,119.11%
|
|
|
|
|
$3.664T
|
+630,609,401,879.35%
|
|
|
|
|
$2.889T
|
+497,289,068,574.70%
|
